MDR-TB in Eastern Europe in the era of the TB elimination action framework

Dudnyk Andrii; Butov Dmytro; Krudu V.; Lange Christoph G.; Chesov Dumitru

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

241

SM ISO690:2012

DUDNYK, Andrii, BUTOV, Dmytro, KRUDU, V., LANGE, Christoph G., CHESOV, Dumitru. MDR-TB in Eastern Europe in the era of the TB elimination action framework. In: International Journal of Tuberculosis and Lung Disease, 2017, nr. 1(21), pp. 2-3. ISSN 1027-3719. DOI: https://doi.org/10.5588/ijtld.16.0732

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

International Journal of Tuberculosis and Lung Disease

Numărul 1(21) / 2017 / ISSN 1027-3719 /ISSNe 1815-7920

MDR-TB in Eastern Europe in the era of the TB elimination action framework

DOI:https://doi.org/10.5588/ijtld.16.0732

Pag. 2-3

Dudnyk Andrii¹, Butov Dmytro², Krudu V.³⁴, Lange Christoph G.⁴⁵⁶⁷, Chesov Dumitru⁴

¹ National Pirogov Memorial Medical University, Vinnytsya,
² National Medical University of Kharkiv,
³ Institute of Phtysiopneumology „Chiril Draganiuc”,
⁴ ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
⁵ Research Center Borstel,
⁶ German Centre for Infection Research (DZIF), Partner Site Hamburg-Luebeck-Borstel-Riems,
⁷ Karolinska Institutet, Stockholm

Disponibil în IBN: 16 martie 2022

Rezumat

SINCE 2011, the Tuberculosis Network European Trials group (TBNET)1 has organised a junior Academy that provides opportunities for medical students and young clinical scientists across Europe to get to know their peers and to become engaged in tuberculosis (TB) related research. The TBNET Academies focus on research priorities and health care inequalities in the European Region.

Cuvinte-cheie
Antitubercular Agents, drug resistance, multiple, Bacterial, Health Services Accessibility, Healthcare Disparities, Humans, Moldova, prognosis, risk factors, tuberculosis, Multidrug-Resistant, Ukraine